FDA
- Status: approved
🇺🇸 0.33% ropivacaine 250ml in United States
0.33% ropivacaine 250ml (0.33% ropivacaine 250ml) regulatory status in United States.
Marketing authorisation
0.33% ropivacaine 250ml in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is 0.33% ropivacaine 250ml approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for 0.33% ropivacaine 250ml in United States?
Guangzhou General Hospital of Guangzhou Military Command is the originator. The local marketing authorisation holder may differ — check the official source linked above.